VNRX Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
VolitionRX Ltd. Stock Analysis VNRX
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. The company is headquartered in Henderson, Nevada and currently employs 110 full-time employees. The company went IPO on 2015-02-06. The firm is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
Read More VNRX Chart
VolitionRX Ltd vs S&P 500 Comparative Returns
Analysis of VNRX stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- VolitionRX Ltd... (VNR...) -14.49%
- S&P 500 -4.27%
VolitionRX Ltd Underperformed S&P 500 by 10.22%
1Y Performance
- VolitionRX Ltd... (VNR...) -29.69%
- S&P 500 8.86%
VolitionRX Ltd Underperformed S&P 500 by 38.55%
3Y Performance
- VolitionRX Ltd... (VNR...) -79.3%
- S&P 500 37.21%
VolitionRX Ltd Underperformed S&P 500 by 116.51%
5Y Performance
- VolitionRX Ltd... (VNR...) -87.56%
- S&P 500 92.3%
VolitionRX Ltd Underperformed S&P 500 by 179.86%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.52Volume
89.58KP/E Ratio (TTM)
-52 Week Range
Market Cap
52.59MAvg. Volume
283.38KDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Revenue per Share (TTM) | 0 | 0 | 0.01 | 0.01 | - |
EBIT per Share (TTM) | -0.44 | -0.53 | -0.55 | -0.44 | - |
EPS Forward | -0.45 | -0.51 | -0.55 | -0.5 | - |
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.